ISIN | CH1416135346 |
---|---|
Valor Number | 141613534 |
Bloomberg Global ID | |
Fund Name | UBS ETF (CH) - UBS SPI® ESG ETF CHF dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund aims to replicate the price and return performance of the SPI® ESG Weighted gross of fees. This sub-fund invests its assets in stocks of companies that are included in the SPI® ESG Weighted and in stocks that are not in the SPI® ESG Weighted but for which notification of their inclusion in this index has been given, and in other investments permitted under the fund contract. In principle, the aim is to match the performance of the SPI ESG Weighted Total Return Index. |
Peculiarities |
Current Price * | 3.46 CHF | 04.06.2025 |
---|---|---|
Previous Price * | 3.44 CHF | 03.06.2025 |
52 Week High * | 3.54 CHF | 21.03.2025 |
52 Week Low * | 2.98 CHF | 09.04.2025 |
NAV * | 3.46 CHF | 04.06.2025 |
Issue Price * | 3.46 CHF | 04.06.2025 |
Redemption Price * | 3.46 CHF | 04.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,375,201,852 | |
Unit/Share Assets *** | 443,773 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
1 month | +1.61% |
05.05.2025 - 04.06.2025
05.05.2025 04.06.2025 |
3 months | -2.15% |
21.03.2025 - 04.06.2025
21.03.2025 04.06.2025 |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 12.35% | |
---|---|---|
Novartis AG Registered Shares | 11.84% | |
Nestle SA | 10.56% | |
Zurich Insurance Group AG | 6.39% | |
ABB Ltd | 5.35% | |
Compagnie Financiere Richemont SA Class A | 5.05% | |
UBS Group AG | 3.73% | |
Swiss Re AG | 3.28% | |
Holcim Ltd | 2.81% | |
Givaudan SA | 2.72% | |
Last data update | 05.05.2025 |
TER | 0.12% |
---|---|
TER date | 20.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.12% |
Ongoing Charges *** | 0.12% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |